Author

V. Cecchinato

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:biophysical modeling· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:protein structure· 1

Frequent Co-Authors

A. Cavalli· 3 shared J. Sgrignani· 3 shared E. M. A. Fassi· 2 shared G. Grazioso· 2 shared M. Garofalo· 2 shared M. Uguccioni· 2 shared A. A. Shanbhag· 1 shared A. Ciurea· 1 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

A. Cavalli

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course

J. Muri, V. Cecchinato, A. Cavalli, A. A. Shanbhag, M. Matkovic, M. Biggiogero, P. A. Maida, J. Moritz, C. Toscano, E. Ghovehoud, R. Furlan, F. Barbic, A. Voza, G. De Nadai, C. Cervia, , Franzetti-Pelland

The paper finds that anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease outcomes and predict absence of long COVID symptoms.

bioRxiv · May 23, 2022 · PreprintImmunology

Systematic development of peptide inhibitors targeting the CXCL12/HMGB1 interaction

J. Sgrignani, V. Cecchinato, E. M. A. Fassi, G. Dagostino, M. Garofalo, G. Danelon, G. Grazioso, M. Uguccioni, A. Cavalli

This study identifies a peptide inhibitor (HBP08) that disrupts the CXCL12/HMGB1 heterocomplex with high affinity, offering potential for treating chronic inflammatory diseases.

bioRxiv · Dec 18, 2019Biochemistry

Oxidation state dependent conformational changes of HMGB1 regulates the formation of the CXCL12/HMGB1 heterocomplex

E. M. A. Fassi, J. Sgrignani, G. D'Agostino, V. Cecchinato, M. Garofalo, G. Grazioso, M. Uguccioni, A. Cavalli

This study shows that the redox state of HMGB1 affects its conformation, enabling complex formation with CXCL12, which enhances leukocyte recruitment via CXCR4.

bioRxiv · May 28, 2019Biochemistry